FDA lifts NOIR at Immucor

The FDA lifts its Notice of Intent to Revoke pertaining to Immucor's (BLUD) Reagent Red Blood Cells and Anti-E (Monoclonal) Blood Grouping Reagent products manufactured at its Norcross, GA facility.

The regulator issued the Notice in 2009 after an on-site inspection revealed significant GMP-related problems.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs